Ticagrelor

CAS Number: 274693-27-5

Molecular Formula: C23H28F2N6O4S

Purity: Ticagrelor 99.77%

About Ticagrelor

Ticagrelor (CAS No: 274693-27-5) is an essential cyclopentyltriazolopyrimidine derivative that serves as a potent, reversibly binding oral P2Y12 receptor antagonist, driving high volume globally in antiplatelet therapies for acute coronary syndrome. Global demand is expanding significantly due to an increasing prevalen...

Synonyms

3-(7-((2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
AZD 6140
AZD-6140
AZD6140
Brilinta

View all

Ticagrelor Specifications

CAS Number

274693-27-5

Molecular Formula

C23H28F2N6O4S

Molecular Weight

522.57 g/mol

IUPAC Name

(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

HSN No

29420090

CAS Number

274693-27-5

Molecular Formula

C23H28F2N6O4S

Molecular Weight

522.57 g/mol

IUPAC Name

(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

HSN No

29420090

Molecular Weight

522.57 g/mol

Purity

Ticagrelor 99.77%

Pharmaceuticals

An antiplatelet drug used to prevent thrombotic events such as heart attack and stroke in patients with acute coronary syndrome

Cardiology

An oral P2Y12 receptor antagonist prescribed to reduce blood clot formation following percutaneous coronary intervention or stent placement

Clinical Research

A key active pharmaceutical ingredient evaluated in clinical trials for secondary stroke prevention and management of coronary artery disease

Combination Therapy

An active component co-administered with low-dose aspirin in dual antiplatelet therapy for cardiovascular care

3-(7-((2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
AZD 6140
AZD-6140
AZD6140
Brilinta